In search of cellular immunophenotypes in the blood of children with autism

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Ashwood, Paul ^a,b   Corbett, Blythe A ^b,d   Kantor, Aaron ^c   Schulman, Howard ^c   van de Water, Judy ^b   Amaral, David G ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Pharmaceutical Product Development   (United States)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD38 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; HLA DR ANTIGEN; MEMBRANE ANTIGEN;

ARTICLE; B LYMPHOCYTE ACTIVATION; BLOOD ANALYSIS; CHILD; CHILD DEVELOPMENT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE DYSREGULATION; IMMUNE STATUS; IMMUNOCOMPETENT CELL; IMMUNOPHENOTYPING; INFANTILE AUTISM; INTELLIGENCE QUOTIENT; LASER SCANNING CYTOMETRY; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; NEUROPATHOLOGY; PRESCHOOL CHILD; T LYMPHOCYTE ACTIVATION; AUTISM; B LYMPHOCYTE; IMMUNOLOGY; METHODOLOGY; T LYMPHOCYTE;

AUTISTIC DISORDER; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOPHENOTYPING; MALE; T-LYMPHOCYTES;

EID: 79955751714     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019299     Document Type: Article

References (56)

1. Lord C, Cook EH, Leventhal BL, Amaral DG, (2000) Autism spectrum disorders. Neuron 28: 355-363.
2. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th ed Washington, D.C.
3. Rice C, (2009) Prevalence of autism spectrum disorders- Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ 58: 1-20.
4. Chakrabarti S, Fombonne E, (2005) Pervasive developmental disorders in preschool children: confirmation of high prevalence. Am J Psychiatry 162: 1133-1141.
5. Abrahams BS, Geschwind DH, (2008) Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 9: 341-355.
6. Ashwood P, Wills S, Van de Water J, (2006) The immune response in autism: a new frontier for autism research. J Leukoc Biol 80 (1): 1-15.
7. Stubbs EG, (1976) Autistic children exhibit undetectable hemagglutination-inhibition antibody titers despite previous rubella vaccination. J Autism Child Schizophr 6: 269-274.
8. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, et al. (2011) Altered T cell responses in autism. Brain Behav Immun (in press) PMID20833247.
9. Molloy CA, Morrow AL, Meinzen-Derr J, Schleifer K, Dienger K, et al. (2006) Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol 172 (1-2): 198-205.
10. Warren RP, Margaretten NC, Pace NC, Foster A, (1986) Immune abnormalities in patients with autism. J Autism Dev Disord 16: 189-197.
11. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA, (2005) Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57 (1): 67-81.
12. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, et al. (2011) Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 25 (1): 40-45.
13. Corbett BA, Kantor AB, Schulman H, Walker WL, Lit L, Ashwood P, et al. (2007) A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins. Molecular Psychiatry 12 (3): 292-306.
14. Enstrom AM, Lit L, Onore CE, Gregg JP, Hansen RL, et al. (2009) Altered gene expression and function of peripheral blood natural killer cells in children with autism. Brain Behav Immun 23 (1): 124-133.
15. Warren RP, Foster A, Margaretten NC, (1987) Reduced natural killer cell activity in autism. J Am Acad Child Adolesc Psychiatry 26: 333-335.
16. Vojdani A, Mumper E, Granpeesheh D, Mielke L, Traver D, et al. (2008) Low natural killer cell cytotoxic activity in autism: the role of glutathione, IL-2 and IL-15. J Neuroimmunol 205 (1-2): 148-54.
17. Enstrom A, Onore C, Van de Water J, Ashwood P, (2010) Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun 24 (1): 64-71.
18. Jyonouchi H, Geng L, Cushing-Ruby A, Quraishi H, (2008) Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study. J Neuroinflammation 5: 52.
19. Warren RP, Yonk LJ, Burger RA, Cole P, Odell JD, Warren WL, White E, Singh VK, (1990) Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism. Immunol Invest 19: 245-251.
20. Yonk LJ, Warren RP, Burger RA, Cole P, Odell JD, Warren WL, White E, Singh VK, (1990) CD4+ helper T cell depression in autism. Immunol Lett 25: 341-345.
21. Plioplys AV, Greaves A, Kazemi K, Silverman E, (1994) Lymphocyte function in autism and Rett syndrome. Neuropsychobiology 29: 12-16.
22. Warren RP, Yonk J, Burger RW, Odell D, Warren WL, (1995) DR-positive T cells in autism: association with decreased plasma levels of the complement C4B protein. Neuropsychobiology 31: 53-57.
23. Cabanlit M, Wills S, Goines P, Ashwood P, Van de Water J, (2007) Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder. Ann NY Acad Sci 1107: 92-103.
24. Wills S, Cabanlit M, Bennett J, Ashwood P, Amaral DG, et al. (2009) Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disorders. Brain Behav Immun 23 (1): 64-74.
25. Croonenberghs J, Wauters A, Devreese K, Verkerk R, Scharpe S, Bosmans E, Egyed B, Deboutte D, Maes M, (2002) Increased serum albumin, gamma globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism. Psychol Med 32: 1457-1463.
26. Enstrom A, Krakowiak P, Onore C, Pessah IN, Hertz-Picciotto I, et al. (2009) Increased IgG4 levels in children with autism disorder. Brain Behav Immun 23: 389-395.
27. Heuer L, Ashwood P, Schauer J, Goines P, Krakowiak P, et al. (2008) Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms. Autism Res 1 (5): 275-83.
28. Gillberg C, Coleman M, (2000) The Biology of the Autistic Syndromes London Mac Keith Press.
29. Krause I, He XS, Gershwin ME, Shoenfeld Y, (2002) Brief report: immune factors in autism: a critical review. J Autism Dev Disord 32: 337-345.
30. Lord C, Rutter M, Goode S, Heemsbergen J, Jordan H, et al. (1989) Autism diagnostic observation schedule: a standardized observation of communicative and social behavior. J Autism Dev Disord 19: 185-212.
31. Le Couteur A, Rutter M, Lord C, Rios P, Robertson S, et al. (1989) Autism diagnostic interview: a standardized investigator-based instrument. J Autism Dev Disord 19: 363-387.
32. Lord C, Pickles A, McLennan J, Rutter M, Bregman J, et al. (1997) Diagnosing autism: analyses of data from the Autism Diagnostic Interview. J Autism Dev Disord 27: 501-517.
33. Lord C, Risi S, Lambrecht L, Cook EH Jr, Leventhal BL, et al. (2000) The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 30 (3): 205-223.
34. Berument SK, Rutter M, Lord C, Pickles A, Bailey A, (1999) Autism screening questionnaire: diagnostic validity. Br J Psychiatry 175: 444-451.
35. Thorndike RL, Hagen EP, Sattler JM, (1986) The Stanford-Binet intelligence scale, fourth edition: guide for administering and scoring Chicago Riverside Publishing Company.
36. Sparrow SS, Balla D, Cicchetti DV, (1984) Vineland Adaptive Behavior Scales (Survey Form) Circle Pines American Guidance Service.
37. Dietz LJ, Dubrow RS, Manian BS, Sizto NL, (1996) Volumetric capillary cytometry: a new method for absolute cell enumeration. Cytometry 23: 177-186.
38. Walton ID, Dietz LJ, Frescatore RL, Chen J, Winkles J, et al. (2000) Microvolume laser scanning cytometry platform for biological marker discovery. Proc SPIE-Int Soc Opt Eng pp. 192-201 IBOS Society of Photo-Optical Instrumentation Engineers.
39. Kantor AB, Alters SE, Cheal K, Dietz LJ, (2004) Immune systems biology: immunoprofiling of cells and molecules. Biotechniques 36: 520-524.
40. Southwick PL, Ernst LA, Tauriello EW, Parker SR, Mujumdar RB, et al. (1990) Cyanine dye labeling reagents-carboxymethylindocyanine succinimidyl esters 166. Cytometry 11: 418-430.
41. Mujumdar RB, Ernst LA, Mujumdar SR, Lewis CJ, Waggoner AS, (1993) Cyanine dye labeling reagents: sulfoindocyanine succinimidyl esters. Bioconjug Chem 4: 105-111.
42. Beavis AJ, Pennline KJ, (1996) Allo-7: a new fluorescent tandem dye for use in flow cytometry 3. Cytometry 24: 390-395.
43. Roederer M, Kantor AB, Parks DR, Herzenberg LA, (1996) Cy7PE and Cy7APC: bright new probes for immunofluorescence 436. Cytometry 24: 191-197.
44. Norton SM, Winkler J, Dietz LJ, (2000) Cell enumeration and characterization in Microvolume Laser Scanning Cytometry:A multicolor image processing package. Proc SPIE-Int Soc Opt Eng 3921: 20-30.
45. Rothman KJ, (1990) No adjustments are needed for multiple comparisons. Epidemiology 1: 43-46.
46. Ashwood P, Anthony A, Pellicer AA, Torrente F, Walker-Smith JA, et al. (2003) Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. J Clin Immunol 23: 504-517.
47. Denney DR, Frei BW, Gaffney GR, (1996) Lymphocyte subsets and interleukin-2 receptors in autistic children. J Autism Dev Disord 26 (1): 87-97.
48. Careaga M, Van de Water J, Ashwood P, (2010) Immune dysfunction in autism: a pathway to treatment. Neurotherapeutics 7 (3): 283-92.
49. Onore C, Krakowiak P, Enstrom A, Hansen R, Hertz-Picciotto I, Van de Water J, Ashwood P, (2009) Decreased cellular IL-23 production in children with autism spectrum disorders. J Neuroimmunol 216 (1-2): 126-129.
50. Ashwood P, Enstrom A, Krakowiak P, Hertz-Picciotto I, Hansen RL, et al. (2008) Decreased transforming growth factor beta1 in autism: A potential link between immune dysregulation and impairment in clinical behavioral outcomes. J Neuroimmunol 204 (1-2): 149-153.
51. Ashwood P, Anthony A, Torrente F, Wakefield AJ, (2004) Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: Mucosal immune activation and reduced counter regulatory interleukin-10. J Clin Immunol 24 (6): 664-673.
52. Ashwood P, Wakefield AJ, (2006) Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J Neuroimmunol 173 (1-2): 126-134.
53. Enstrom A, Onore C, Hertz-Picciotto I, Hansen R, Croen L, Van de Water J, Ashwood P, (2008) Detection of IL-17 and IL-23 in Plasma Samples of Children with Autism. American Journal of Biochemistry and Biotechnology 4: 114-120.
54. Grigorenko EL, Han SS, Yrigollen CM, Leng L, Mizue Y, Anderson GM, Mulder EJ, de Bildt A, Minderaa RB, Volkmar FR, Chang JT, Bucala R, (2008) Macrophage migration inhibitory factor and autism spectrum disorders. Pediatrics 122: e438-445.
55. Tsuchiya KJ, Hashimoto K, Iwata Y, Tsujii M, Sekine Y, et al. (2007) Decreased serum levels of platelet-endothelial adhesion molecule (PECAM-1) in subjects with high-functioning autism: a negative correlation with head circumference at birth. Biol Psychiatry 62: 1056-1058.
56. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J, (2011) Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J Neuroimmunol 232 (1-2): 196-199.